Main Findings
In this study, we assessed the potential causal links between 731 immune cell phenotypes and stroke and its subtypes. Following FDR correction, we found no immune cells causally associated with stroke, ICH, ischemic stroke, or cardioembolic stroke. However, we identified four immune cell types that increase the risk of large artery stroke and one that increases the risk of small vessel stroke. Through reverse MR analysis, we confirmed that there is no reverse causal relationship between stroke and its subtypes and immune cell phenotypes. Additionally, to strengthen the reliability of our primary findings, we conducted secondary MR analyses using different datasets to validate our discoveries. This approach significantly enhances the credibility of our results, an aspect often lacking in many current MR studies.
Our findings are robust, as confirmed by sensitivity analyses and pleiotropy tests. Current research suggests that although IVW is less robust, it provides more accurate estimates in the absence of horizontal pleiotropy [
16]. Our MR-pleiotropy tests and MR-PRESSO Global Test results suggest no presence of horizontal pleiotropy. Therefore, we consider IVW as our primary reference method, and when IVW’s
PFDR is < 0.05, and the other two methods concur in direction, we regard the causal association as present.
We opted for the FDR method for multiple testing correction owing to its ability to strike a good balance in controlling the FDR. This approach maintains a lower rate of false findings while preserving greater statistical power, particularly beneficial when dealing with large datasets. Its advantage lies in allowing a certain proportion of false positives, thereby reducing the likelihood of type II errors (false negatives), which is especially important in exploratory research. However, we acknowledge that no statistical method is perfect, and we cautiously consider our research conclusions to be statistically significant, albeit subject to validation by further experimental studies.
Relationship Between Immune Cells and Stroke and Its Subtypes
CD45RA and CD28 are important surface markers of T cells, with CD45RA typically associated with the differentiation of naïve and memory T cells. At the same time, CD28 is a major co-stimulatory receptor for T cell activation [
17‐
19]. A specific T cell subset, CD45RA
+CD28
−CD8
+ T cells, may play a significant role in the immune response following stroke. T cell responses can be observed within 24 h post-ischemic stroke, and T cells remain active in the brain for at least 30 days, underscoring their importance in neuroprotection and inflammation post-stroke. The CD45RA
−CD28
− phenotype may represent T cell subsets with different functions and maturation states. For instance, CD8
+CD45RA
− T cells exhibit increased cytokine secretion, potentially impacting inflammation and aging processes, thus correlating with an increased risk of large artery stroke [
20].
Literature informs us that cerebral small vessel disease (CSVD) is closely related to immune responses and inflammatory reactions. Inflammatory mediators and lymphocytes significantly contribute to the development of brain injury and neurological deficits post-acute ischemic stroke or cerebral hemorrhage due to large artery occlusion. It is also mentioned that immunosenescence and inflammatory responses, along with their interaction with the cerebrovascular system, may be underlying factors for CSVD [
21]. This could hint at the potential role of switched memory B cells in small vessel stroke, although their specific pathophysiological roles still need further clarification.
Further exploring the association with large artery stroke, we note that CD27 is an important immunoregulatory molecule playing a crucial role in the activation and differentiation of B and T cells. From a broader perspective, the role of immune responses in CSVD, including inflammation and immune reactions associated with pathological changes in cerebral microvasculature, may provide clues for understanding the association between immune cell phenotypes and large artery stroke [
22,
23]. Additionally, CSVD is a significant cause of vascular dementia and is closely linked to cognitive decline and functional loss in the elderly [
21].
T cell effector functions can be observed within 24 h post-ischemic stroke, with T cells remaining active in the brain for at least 30 days. Eliminating CD4
+ or CD8
+ T cell subsets within 24 h post-ischemic stroke can reduce infarct volume [
24]. Human naïve and memory T cells can be distinguished on the basis of the expression of surface molecules (including CD45RA) [
19]. Utilizing CD45RA and CD28 helps to examine two effector memory groups at early and late differentiation stages, which might relate to the association of CD45RA
+CD28
−CD8
+ T cells with stroke subtypes [
25].
Stroke triggers a complex innate and adaptive immune response, including immune cell-mediated and factor-mediated vascular and tissue damage. Modulating immunity in stroke is of paramount importance [
26]. There is increasing evidence of an adaptive (or maladaptive) immune response following ischemic stroke, indicating a complex role of the immune system in the pathogenesis of stroke [
27]. Time is a critical determinant of whether immunity and inflammation in stroke are neuroprotective or neurotoxic, while the local inflammatory milieu significantly affects many proposed therapeutic approaches [
28]. Particularly, Treg cells play a key role in immunoregulation in ischemia–reperfusion injury, a core aspect of stroke pathophysiology [
29].
Strengths and Limitations
Our comprehensive analysis of the causal relationships between 731 immune cell types and six stroke subtypes used a variety of MR methods to ensure the robustness of the results, free from confounding by horizontal pleiotropy and other factors. Our study reveals partial causal relationships between certain immune cells with large artery stroke and small vessel stroke, providing a reference for subsequent prevention, treatment, and drug development related to these diseases. However, our study has limitations. Firstly, as a result of sample restrictions, our study population included only Europeans. While this avoids the potential influence of different populations on the results, it limits the generalizability of our findings to other populations. Secondly, as a result of limitations in the data, we were unable to perform further stratified analyses of the population. Furthermore, when delving into more detailed subtype analyses, such as the distinctions between ischemic and hemorrhagic types in CSVD with respect to immune cell types [
30], we were unable to conduct further analysis. Finally, in some conclusions, the IVW results were positive, while the MR-Egger and weighted median methods were negative. Although we have explained this phenomenon on the basis of current theories, we cannot completely exclude the possibility of false positives in these results.
Reflections on Future Research
In this study, through the application of MR analysis, we preliminarily explored the causal associations between 731 types of immune cells and six subtypes of stroke. It is our hope that future research will build upon this foundation to delve deeper into the specific roles of different immune cells in the onset and progression of stroke, thereby contributing to a more nuanced understanding of disease mechanisms. Additionally, examining the interactions between immune cells and the recovery process in patients with stroke may provide valuable insights for enhancing rehabilitation strategies. Further understanding of how immune cells influence the long-term prognosis of stroke could significantly impact patient quality of life. On a technical level, advancements in high-throughput sequencing and single-cell technologies present us with unprecedented opportunities to study immune cells in stroke with remarkable resolution. Lastly, it is important to note the existence of certain stroke subtypes characterized by diagnostic challenges, often referred to as cryptogenic strokes or strokes of undetermined origin. These cases are not uncommon in clinical practice but pose complexities in management and treatment due to the absence of a clear etiology. Future research could investigate the role and impact of immune cell types in these challenging stroke subtypes, potentially improving our understanding of stroke pathophysiology and paving the way for the development of new diagnostic tools and treatment strategies.